HR Execs on the Move

TemPharma

www.tempharma.com

 
TemPharma is a Plainsboro, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Memorial Health System of East Texas

Memorial Health System of East Texas, doing business as Memorial Medical Center of East Texas, operates not-for-profit hospitals in Lufkin, Livingston, and San Augustine. It offers diabetes, dialysis, emergency, homecare, lab imaging, intensive care, orthopedics, rehabilitation, robotic surgery, sexual assault nurse examiner, sleep lab, social, stroke, surgery, and wound care and hyperbaric oxygen services, as well as cancer, cardiovascular and stroke, infusion, ambulatory, and women’s and children’s center services. The company was founded in 1949 and is based in Lufkin, Texas.

Outpatient Imaging

Outpatient Imaging is a medical imaging center that offers a variety of diagnostic tests and procedures. Patients have the power to choose which imaging center performs their exam, as mandated by law in Georgia.

Dogwood Forest Of Alpharetta

Dogwood Forest Of Alpharetta is a Alpharetta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Universal Endoscopic Svc Inc

Universal Endoscopic Svc Inc is a Fort Lauderdale, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Oklahoma Medical Research Foundation

Established in 1946, OMRF is an independent, nonprofit biomedical research institute with more than 450 staff and over 50 labs studying cancer, heart disease, autoimmune disorders, and diseases of aging. Breakthroughs in our labs have led to three FDA-approved drugs, including the first targeted therapy approved in the U.S. for sickle cell disease and the first approved treatment for neuromyelitis optica spectrum disorder, a rare autoimmune disease. OMRF`s critical research is helping people live longer, healthier lives, one discovery at a time. Along the way, OMRF has garnered worldwide media attention, from leading scientific publications like The New England Journal of Medicine and Science to The New York Times and The Wall Street Journal. By pushing the boundaries of biomedical science, our researchers are helping to win the war against human disease, one discovery at a time.